Important Notices

Gamunex-C Lot Withdrawn
March 05, 2025
On Feb. 20, 2025, Grifols Therapeutics LLC withdrew one lot Gamunex-C® (immune globulin injection [human], 10% caprylate/chromatography purified) 40G vial to the consumer level for due to an increased rate of reported hypersensitivity reactions with the affected lot.
Learn more
Fentanyl Transdermal Recalled
February 21, 2025
On Jan. 31, 2025, Alvogen, Inc. issued a recall for one lot to the consumer level for Fentanyl Transdermal System 25 mcg/h transdermal patches.
Learn more
Orders may arrive late due to Winter Weather
February 18, 2025

Orders may arrive late due to Winter Weather. We are working with our carriers, so you receive your medication as soon as possible. Please check your tracking information for the latest updates. Express Scripts sends our best wishes for your safety during this time. Thank you!

Learn more
Additional Lot of Xembify Withdrawn
February 11, 2025
On Jan. 10, 2025, Grifols Therapeutics LLC withdrew one lot to the consumer level for Xembify® (immune globulin subcutaneous, human-klhw) 20% 4G vial due to an increased rate of reported hypersensitivity reactions with the affected lot.
Learn more
Epinephrine Nasal Solution - FDA Warning
January 22, 2025
On Jan. 16, 2025, the FDA warned healthcare professionals not to use unapproved epinephrine nasal solutions from BPI Labs and Endo
Learn more
One Lot of Xembify Withdrawn
January 17, 2025
On Jan. 13, 2025, Grifols Therapeutics LLC withdrew one lot to the consumer level for Xembify® (immune globulin subcutaneous, human-klhw) 20% 4G vial
Learn more
Orders may be delayed due to Winter Weather
January 06, 2025
Orders may arrive late due to Winter Weather.
Learn more
Systane Eye Drops Recalled
December 30, 2024
On Dec. 21, 2024, Alcon Laboratories recalled one lot of Systane® Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count to the consumer level.
Learn more
Adrenalin Recalled
December 30, 2024
On Dec. 20, 2024, Endo, Inc., the parent company of Par Pharmaceutical, recalled six lots of Adrenalin® Chloride Solution
Learn more
Clonazepam Orally Disintegrating Tablets Recall
November 22, 2024
On Nov. 19, 2024, Endo Pharmaceuticals, the parent company of Par Pharmaceuticals, notified the FDA of an expansion of its voluntary recall of Clonazepam Orally Disintegrating Tablets
Learn more